Entelos Collaborates With Novartis On In Silico Drug Trials
Filed in archive Corporate and Industrial News , Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on August 23, 2006

Entelos, Inc. is a US-based life sciences company which creates computer models of human physiologyEntelos just entered into a research agreement with Novartis AG to predict the effect of Novartis' drug candidates on "virtual patients" using Entelos' PhysioLab® platforms.designed to reduce the risk, time, and cost of drug discovery and development. The Company's portfolio of proprietary computer models, known as PhysioLab systems, have helped its pharmaceutical customers validate novel drug targets, select and develop compounds, optimize clinical trials, evaluate in-licensing candidates, and better position existing products in competitive markets.
[Photo: Entelos]
Permalink: Entelos Collaborates With Novartis On In Silico Drug Trials
Tags:
bioinformatics drug
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/34085







